Literature DB >> 30726818

[Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].

Kyoko Itakusu1, Tomonori Inoue1, Masaya Abe1, Ryo Ueda1, Aki Sakurai1, Yukihiro Miyazaki1, Koichi Nakase1, Isao Yoshida2, Yuichiro Nawa1.   

Abstract

A 63-year-old woman was admitted to our hospital with relapsed acute myeloid leukemia. On day10 after reinduction therapy, she became febrile. Computed tomography on day15 revealed right upper lobe consolidation. Because the β-D glucan and Aspergillus galactomannan antigen tests were negative, we considered pulmonary mucormycosis as a breakthrough infection under voriconazole administration. Liposomal amphotericin B was initiated, and the patient underwent unrelated bone marrow transplantation although not in complete remission. She developed right shoulder pain on day1, and her pneumonia worsened on day3. She reported right lower extremity paralysis on day15, and developed bilateral lower extremity motor and sensory paralysis the next day. T2-enhanced magnetic resonance imaging revealed hyperdense lesions in the spinal cord at Th11. Transverse myelitis was diagnosed, and she underwent antiviral therapy. After engraftment, she died of pneumonia on day24. Postmortem examination revealed disseminated mucormycosis involving the lungs, liver, diaphragm, blood vessels, and dura matter of the spinal cord; it also revealed that the sudden bilateral lower extremity paralysis was caused by disseminated mucormycosis. This case stresses the possibility of mucormycosis, particularly in prolonged neutropenic patients with pain, fever, and focal neurological findings.

Entities:  

Keywords:  Acute myeloid leukemia; Mucormycosis; Unrelated bone marrow transplantation

Mesh:

Substances:

Year:  2019        PMID: 30726818     DOI: 10.11406/rinketsu.60.17

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  1 in total

1.  Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.

Authors:  Isao Yoshida; Akiko M Saito; Shiro Tanaka; Ilseung Choi; Michihiro Hidaka; Yasuhiko Miyata; Yoshiko Inoue; Satoshi Yamasaki; Toshiya Kagoo; Hiroatsu Iida; Hiromasa Niimi; Takuya Komeno; Chikamasa Yoshida; Fumihito Tajima; Hideyuki Yamamoto; Ken Takase; Hironori Ueno; Takeshi Shimomura; Tatsunori Sakai; Yasuhiro Nakashima; Chikashi Yoshida; Shiro Kubonishi; Kazutaka Sunami; Shinichiro Yoshida; Aki Sakurai; Yukihiro Kaneko; Yoshitsugu Miyazaki; Hirokazu Nagai
Journal:  Mycoses       Date:  2020-05-28       Impact factor: 4.377

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.